Severe Hyperkalemic Type 4 Renal Tubular Acidosis After Kidney Transplantation: A Case Report

Transplantation Proceedings

Volumn 38, Issue 9, 2006, Pages 3112-3115

  Rangel, E B ^a   Gomes, S A ^a   Machado, P G ^a   Cardoso dos Santos, B F ^a   Medina Pestana, J O ^a   Pacheco Silva, A ^a   Heilberg, I P ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALKALI; ANION; BICARBONATE; CREATININE; FLUDROCORTISONE; FUROSEMIDE; GLUCONATE CALCIUM; MINERALOCORTICOID; POTASSIUM;

ACIDOSIS; ADOLESCENT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD PH; CADAVER; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG RESPONSE; EMERGENCY WARD; HUMAN; HYPERCHLOREMIA; HYPERKALEMIA; KIDNEY GRAFT; KIDNEY TUBULE NECROSIS; MALE; METABOLIC ACIDOSIS; MUSCLE WEAKNESS; PHYSICAL EXAMINATION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; URINE PH;

ACIDOSIS, RENAL TUBULAR; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BICARBONATES; CADAVER; DIETARY SUPPLEMENTS; ELECTROCARDIOGRAPHY; FLUDROCORTISONE; HUMANS; HYPERKALEMIA; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 33750939790     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.110     Document Type: Article

References (16)

1. Palmer B.F. Managing hyperkalemia caused by inhibition of the rennin-angiotensin-aldosterone system. N Engl J Med 351 (2004) 582
2. Heering P., Degenhardt S., and Grabensee B. Tubular dysfunction following kidney transplantation. Nephron 74 (1996) 501
3. Soriano J.R. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 13 (2002) 2160
4. +-ATPase activity by cyclosporin A. Kidney Int 43 (1993) 246
5. Aker S., Heering P., Kinne-Saffran E., et al. Different effects of cyclosporine A and FK506 on potassium transport systems in MDCK cells. Exp Nephrol 9 (2001) 332
6. Heering P.J., Klein-Vehne N., and Fehsel K. Decreased mineralocorticoid receptor expression in blood cells of kidney transplant patients undergoing immunosuppressive treatment: cost efficient determination by quantitative PCR. J Clin Pathol 57 (2004) 33
7. Deppe C.E., Heering P.J., Viengchareun S., et al. Cyclosporine and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology 143 (2002) 1932
8. Heering P.J., Kurschat C., Vo D.T., et al. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression. Clin Transplant 18 (2004) 186
9. Pei Y., Richardson R., Greenwood C., et al. Extrarenal effect of cyclosporine A on potassium homeostasis in renal transplant recipients. Am J Kidney Dis 22 (1993) 314
10. Eiam-Ong S., Kurtzman N.A., and Sabatini S. Studies on the mechanism of trimethoprim-induced hyperkalemia. Kidney Int 49 (1996) 1372
11. Koc M., Bihorac A., Ozener C.L., et al. Severe hyperkalemia in two renal transplant recipients treated with standard dose of trimethoprim-sulfamethoxazole. Am J Kidney Dis 36 (2000) E18
12. Perazella M.A., and Mahnensmith R.L. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose. Clin Nephrol 46 (1996) 187
13. Velázquez H., Perazalla M.A., Wright F.S., et al. Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 119 (1993) 296
14. Heering P., and Grabensee B. Influence of cyclosporine A on renal tubular function after kidney transplantation. Nephron 59 (1991) 66
15. Heering P., Ivens K., Aker S., et al. Distal tubular acidosis induced by FK506. Clin Transplant 12 (1998) 465
16. Cho B.S., Kim H.S., Jung J.Y., et al. Severe renal tubular acidosis in renal transplant recipient with repeated acute rejections and chronic allograft nephropathy. Am J Kidney Dis 41 (2003) E6